2TP-24992-82876
3 vaccinations
6 coded responses
36 check-ins
6 free-text entries
3 call cases
- Sex
- Female
- Age at first dose
- 21-25
- ZIP prefix
- 967 / HI
- Registered
- 2021-03-09
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-09
Registered in v-safe
-
2021-03-09
Dose 1 — Pfizer-BioNTech
- 2021-03-09
- 2021-03-10
-
2021-03-11
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain, Swelling · Diarrhea, Rash, not including the immediate area around the injection site · Be unable to do your normal daily activitiesAdult check-in
-
2021-03-12
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Joint pains, Diarrhea, Rash, not including the immediate area around the injection site · Be unable to do your normal daily activitiesAdult check-in
-
2021-03-13
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Joint pains, Fatigue or tiredness, Diarrhea · Be unable to do your normal daily activitiesAdult check-in
-
2021-03-14
Health check-in — days 1–6 daily, dose 1Feeling: Poor · Fever · Headache, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
- 2021-03-15
-
2021-03-16
Health check-in — day 7, dose 1Feeling: Fair · Site: Swelling, Itching · Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-03-23
Survey response — day 14, dose 1MedDRA: Arthralgia, Fatigue, Impaired work ability, Loss of personal independence in daily activities — Feeling: Good · Be unable to work, Be unable to do your normal daily activitiesFree text: Joint pain and extreme fatigue, barely able to work and collapsed when I got home, not able to make myself dinner or take the dog for a walkMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-30
Dose 2 — Pfizer-BioNTech
-
2021-03-30
Health check-in — day 0, dose 2Feeling: Fair · Site: Pain · Fever · Headache, NauseaAdult check-in
-
2021-03-31
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Redness, Itching · Headache, Muscle or body aches, Fatigue or tiredness, Nausea, Rash, not including the immediate area around the injection site · Be unable to do your normal daily activitiesAdult check-in
-
2021-04-01
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Swelling, Itching · Headache, Joint pains, Fatigue or tiredness, Diarrhea, Rash, not including the immediate area around the injection siteAdult check-in
-
2021-04-02
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Itching · Headache, Joint pains, Diarrhea, Rash, not including the immediate area around the injection siteAdult check-in
-
2021-04-03
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Headache, Muscle or body aches, Fatigue or tiredness, Nausea, Vomiting, Rash, not including the immediate area around the injection site · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-04-04
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, NauseaAdult check-in
-
2021-04-05
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Itching · Fever · Headache, Fatigue or tiredness, Rash, not including the immediate area around the injection site · Be unable to do your normal daily activitiesAdult check-in
-
2021-04-06
Health check-in — day 7, dose 2Feeling: Good · Headache, Diarrhea, Rash, not including the immediate area around the injection site · Be unable to do your normal daily activitiesAdult check-in
- 2021-04-13
-
2021-04-20
Survey response — day 21, dose 2MedDRA: Aphonia, Diarrhoea, Fatigue, Joint swelling, Respiratory tract congestion — Feeling: Good · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Congestion, lost voice, migraines, fatigue, diarrhea, swollen jointsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-20
Report sent to call center — day 21, dose 2Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-04-27
Survey response — day 28, dose 2MedDRA: Migraine — Feeling: Fair · Be unable to do your normal daily activitiesFree text: MigrainesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-05-04
-
2021-05-11
Survey response — day 42, dose 2MedDRA: Fatigue, Migraine, Pre-existing disease — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Worsening migraines and fatigueMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-11
Report sent to call center — day 42, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-06-29
-
2021-09-28
Survey response — 6 months, dose 2MedDRA: Chapped lips — Feeling: Fair · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: Chronic cracked lipsMedDRA releases: 2024-11 · check-in free text available
-
2021-09-28
Report sent to call center — 6 months, dose 2Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
- 2021-10-01
-
2021-10-02
Dose 3 — Pfizer-BioNTech
- 2021-10-02
-
2021-10-03
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-10-04
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Site: Pain · Headache, Fatigue or tiredness, Rash, not including the immediate area around the injection site · Be unable to do your normal daily activitiesAdult check-in
-
2021-10-05
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Fatigue or tiredness, Rash, not including the immediate area around the injection siteAdult check-in
-
2021-10-07
Health check-in — days 1–6 daily, dose 3Feeling: Good · Rash, not including the immediate area around the injection siteAdult check-in
-
2021-10-08
Health check-in — days 1–6 daily, dose 3Feeling: Good · Rash, not including the immediate area around the injection siteAdult check-in
-
2021-10-09
Health check-in — day 7, dose 3Feeling: Good · Rash, not including the immediate area around the injection siteAdult check-in
- 2021-10-23
- 2021-10-30
- 2021-11-06
-
2021-11-13
Survey response — day 42, dose 3MedDRA: Fatigue, Somnolence — Feeling: Good · Be unable to do your normal daily activitiesFree text: Absolute exhaustion to the point of falling asleep on lunch break at work and falling asleep within 1-2 hours of getting home and still just feeling wiped outMedDRA releases: 2024-11 · check-in free text available
- 2022-01-01
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-09 | Pfizer-BioNTech | |
| 2 | 2021-03-30 | Pfizer-BioNTech | |
| 3 | 2021-10-02 | Pfizer-BioNTech | No |
Call center
3 call center cases
3 unsuccessful
Free text
Release 6 — day 14, dose 1
Symptoms: Joint pain and extreme fatigue, barely able to work and collapsed when I got home, not able to make myself dinner or take the dog for a walk
Release 7 — day 21, dose 2
Symptoms: Congestion, lost voice, migraines, fatigue, diarrhea, swollen joints
Release 8 — day 28, dose 2
Symptoms: Migraines
Release 8 — day 42, dose 2
Symptoms: Worsening migraines and fatigue
Release 9 — 6 months, dose 2
Symptoms: Chronic cracked lips
Release 10 — day 42, dose 3
Symptoms: Absolute exhaustion to the point of falling asleep on lunch break at work and falling asleep within 1-2 hours of getting home and still just feeling wiped out
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Aphonia | ✓ | ✓ | ✓ |
| SD | Arthralgia | ✓ | ✓ | ✓ |
| SD | Chapped lips | · | · | ✓ |
| SD | Diarrhoea | ✓ | ✓ | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Impaired work ability | ✓ | ✓ | ✓ |
| SD | Joint swelling | ✓ | ✓ | ✓ |
| SD | Loss of personal independence in daily activities | ✓ | ✓ | ✓ |
| SD | Migraine | ✓ | ✓ | ✓ |
| SD | Pre-existing disease | ✓ | ✓ | ✓ |
| SD | Respiratory tract congestion | ✓ | ✓ | ✓ |
| SD | Somnolence | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release